Although this scheme explains a great deal about Gprotein-mediated signal transduction, it does not explain everything. For example, the rate of GTP hydrolysis by isolated G␣ subunits is frequently very much slower than the turn-off rate of the reactions they control. Thus, the visual response to light is initiated by activation of rhodopsin, and transmitted by activation of the retinal G protein transducin (G t ) and the subsequent activation of retinal cGMP phosphodiesterase. The half-time of GTP hydrolysis on the G␣ t subunit is about 10-20 seconds, but everyone knows that when one's eyes close, the image disappears instantaneously. There are other examples of such disparities between the rate at which physiological responses are terminated, and the rate at which GTP is hydrolyzed on the relevant G␣ subunit.
One possibility is that the rate of GTP hydrolysis by isolated G␣ subunits is artificially slow. For example, at least two effectors activate the GTPase activity of the GTP-liganded G␣ subunit that they bind. The effectors known to act as GTPase-activating proteins (GAPs) are cGMP phosphodiesterase, which increases the rate of GTP hydrolysis by G␣ t , and phospholipase C, which increases the rate of GTP hydrolysis by G␣ q . However, the GAP activity of cGMP phosphodiesterase is modest compared to the increase in rate required to explain the lack of after-image when one closes one's eyes (see references in [1] ).
In the last year, a large family of proteins relevant to this puzzle has burst on the scene. These are the 'regulators of G-protein signalling' (RGS), of which about twenty are currently known. All of these proteins share regions of sequence similarity to the Saccharomyces cerevisiae protein known as Sst2 ( [2] and references therein), the absence of which causes yeast to be supersensitive to mating pheromone. In yeast, the mating pheromone uses signal transduction machinery similar to that described above to initiate growth arrest and other phenotypic changes. The accumulated genetic evidence suggested that Sst2 requires the presence of the yeast G␣ subunit (Gpa1) and might act as a GAP for Gpa1.
The development of the RGS story is a wonderful example of the coalescence of information from very different systems into new awareness of a common mechanism. Genetic analysis in the nematode Caenorhabditis elegans revealed a gene, egl-10, that encodes a protein very similar in its carboxy-terminal region to a portion of Sst2. The absence of Egl-10 causes a decrease in the frequency of egg laying, a function mediated by serotonergic motor neurons [3] . Just as the function of Sst2 in yeast depends on the presence of an intact Gpa1, the function of Egl-10 in worms depends on the presence of a G␣ protein known as Goa-1. Taken together, the results suggest that Sst2 and Egl-10 might have a common mechanism of action, and that both might be negative regulators of the function of a G␣ subunit.
A totally independent approach revealed another protein with a sequence related to Sst2. This time the protein, called GAIP, was identified on the basis of its ability to bind to a fusion protein containing G␣ i-3 [4] . Database searches [3, 4] revealed that the new proteins belonged to a family of proteins, some of which were known only as expressed sequences, and others of which had been previously studied. The latter proteins include one, BL34, found in lymphocytes, and one, GOS8, found in cells of both the myeloid and lymphoid lineages (see references in [3] ). GOS8 is not only similar in sequence to Sst2, but can substitute for its function when placed into sst2 -mutant yeast cells [5] . Another RGS protein, RGS4, has been shown both to complement lack of Sst2 in mutant yeast cells and to blunt signal transduction through mammalian G-protein-coupled receptors [6] , reinforcing the idea that Sst2 and its homologues have similar actions.
How do these negative regulators of G-protein function actually do their job? Three groups have shown that several RGS proteins are extremely effective GAPs for G␣ subunits [7] [8] [9] in the G␣ o /G␣ i family; none has yet been found for G␣ s . The GTPase activity of all G␣ subunits is limited by the rate of GDP release. The RGS proteins have no effect on GDP release, and therefore they do not increase the steady-state turnover of GTP. To demonstrate the GTPase-activating function, therefore, the assay must be set up to measure the single-cycle rate of GTP hydrolysis. In such assays, the G protein is loaded with radioactive GTP under conditions where no hydrolysis occurs (absence of Mg 2+ ), and hydrolysis is started by addition of Mg 2+ . With such an assay, the RGS proteins are found to increase the rate of hydrolysis by over 40-fold [7] [8] [9] . The RGS protein must normally act in concert with activated receptors that promote GDP release to produce an increase in the rate of steady-state GTP hydrolysis.
Clues to the mechanism of action of the RGS proteins came from the observation that RGS4 binds more effectively to the GDP-AlFl 4 -form of the G␣ subunit than to the GTP␥S-liganded form [8] . GDP-AlFl 4 -is thought to mimic the transition state for the GTPase reaction, so the suggestion is that RGS proteins speed up the hydrolysis reaction by stabilizing the transition state [10] . The mechanism seems not to be unique to the heterotrimeric G proteins, because the small GTP-binding protein Ras, which ordinarily does not bind AlFl 4 -, can do so in the presence of its GAP [11] . Analysis of the interaction of Ras with RasGAPs suggests that amino-acid side chains from RasGAP participate in accelerating the GTP cleavage step itself [11] .
If GAPs for heterotrimeric G proteins work in a similar way to RasGAPs, it is likely that RGS proteins will bind near the active site of G␣ subunits and not exert their action by conformational changes at a distance. From that contact point, they could increase GTPase activity by a mixture of direct involvement in catalysis and of conformational stabilization. The point in the activation cycle at which the RGS protein does its job is not yet clear, however. The RGS protein can certainly bind to the free GTP-liganded G␣ subunit, increasing the rate of GTP hydrolysis and keeping it from ever interacting with an effector protein. If RGS proteins bind near the active site, they are likely to impinge on effector binding sites. Nevertheless, should the RGS and effector binding sites on G␣ not overlap, the RGS protein may pounce on the G␣-effector complex and decrease the duration of activation.
So far, RGS proteins have been discussed as if they are all essentially alike, but, in fact, there is a great deal of variation among them. Some RGS proteins seem to consist exclusively of the RGS domain and are predicted to be small proteins of ~20 kDa. Other RGS proteins have large extensions, whose function is not yet known. Indeed, some signs of specificity are beginning to emerge. Different RGS proteins are not equally effective GAPs for different G␣ subunits, and there are substantial differences in the kinetic parameters V max and K m when different RGS proteins are tested against a single G␣ R32 Current Biology, Vol 7 No 1 Figure 1 The regulatory cycle of G proteins. The ligand-receptor (L-R) complex interacts with the heterotrimeric G protein (␣␤␥). The receptor interacts with the inactive state of the G protein, in which the ␣ subunit is bound to GDP. Interaction with the receptor lowers the affinity of the G␣ subunit for GDP, so that the nucleotide is released and its place taken by GTP. GTP binding induces G␣ to change conformation to the active state, dissociate from the G␤␥ dimer and interact with an effector (E1) to perform its regulatory function. The free G␤␥ dimer activates its own effector (E2). The recently discovered 'regulators of G-protein signalling' (RGS) interact with a G␣ subunit, either free or bound to an effector, in such a way as to speed up the termination of signalling (see text for details). . RGS proteins also vary in their tissue distribution. Some appear to be expressed exclusively in brain, others in myeloid or lymphoid cells; still others seems to be rather broadly distributed. At present, however, the analysis of the distribution and development of RGS proteins is still extremely rudimentary.
The subcellular localization of the RGS proteins is also likely to vary. Some are predicted to be extremely hydrophilic proteins that are likely to be found in the cytoplasm. In contrast, others, such as GAIP, are palmitoylated, strongly attached to the membrane and difficult to extract (L. De Vries, E. Elenko, L. Hubler, T.L.Z. Jones and M.G. Farquhar, personal communication). Sst2 is also membrane-bound [2] . As an RGS protein has to act rather rapidly after hormonal activation of a G␣ subunit, the tight association of an RGS protein with the membrane suggests that it may be localized to a submembrane compartment that also contains receptors and G proteins. It has been suggested that one such compartment is the caveolae, but it is not yet known whether RGS proteins are located there. It will be important to establish each of these points in order to begin to suggest functions for individual members of the RGS family.
In addition to providing a possible answer to an important, unanswered question about how transmembrane signals are rapidly turned off, RGS proteins may also play a part in the more long-term regulation of signalling. In yeast, the phenotype of sst2 -cells is a failure to desensitize to pheromone after prolonged exposure. In mammalian cells, desensitization is a well-studied phenomenon in which receptor-specific and non-specific protein kinases play important roles. It is possible that RGS proteins also play a role in desensitization in mammalian cells, if their level increases or location changes with exposure to agonist.
Another form of modulation of signalling responsiveness occurs in response to normal or pathological demands placed on the organism. For example, in cardiac failure, there is a general blunting of responsiveness to ␤-adrenergic receptors that is accompanied by slow and modest changes in receptor and/or G-protein levels. In contrast, there is evidence that the levels of RGS proteins may change substantially under different physiological conditions (references in [2] ). Regulating the level of the RGS protein would provide a mechanism for critically tuning the system without changing the levels of the primary signalling components, the receptors, G proteins or effectors.
